6 line items for fluoxetine HCL capsules. Awarded for a base year of 12/10/2022 to 12/09/2023 plus four one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79722D0035
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Fluoxetine HCL Capsules Pre-Solicitation · 36E79722R0023 · Posted Jun 29, 2022
- Last date to order 98% complete
- IDV ceiling
- $10,673,128.95
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The General Services Administration's National Acquisition Center awarded a single-award indefinite-delivery contract to Radha Pharmaceuticals Inc. on December 10, 2022, for fluoxetine HCL capsules with a ceiling value of $10,673,128.95. The contract runs from December 10, 2022, through December 9, 2023, as a base year, plus four one-year option periods extending through December 9, 2026. The solicitation, posted June 29, 2022, covered six line items for fluoxetine HCL capsules in various strengths and bottle configurations to support federal government pharmaceutical supply requirements. The contract incorporates FAR clause 52.222-90 (Paid Sick Leave). Radha Pharmaceuticals Inc. is a minority-owned manufacturer and distributor of generic pharmaceuticals supplying tablets, capsules, and other drug products to federal customers including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The award was made under full and open competition with no set-aside applied. Task orders placed under this IDIQ provide an uninterrupted supply of fluoxetine HCL to government medical facilities, with estimated requirements exceeding 200,000 units annually across various federal customer locations and dosage strengths.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79722D0035?
36E79722D0035 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on December 10, 2022.
How much is contract 36E79722D0035 worth?
36E79722D0035's own ceiling is $10,673,129.
Who can order from contract 36E79722D0035?
36E79722D0035 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36E79722D0035 competed?
The extent of competition for 36E79722D0035 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV